Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo
Neomorphic mutations in isocitrate dehydrogenase 1 (IDH1) are frequently found in several human cancer types including acute myeloid leukemia (AML) and lead to the production of high levels of the oncometabolite (R)-2-hydroxyglutarate (R-2HG). Here we report the characterization of BAY1436032, a nov...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
24 February 2017
|
| In: |
Leukemia
Year: 2017, Jahrgang: 31, Heft: 10, Pages: 2020-2028 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/leu.2017.46 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1038/leu.2017.46 Verlag, Volltext: https://www.nature.com/leu/journal/vaop/ncurrent/full/leu201746a.html 
|
| Verfasserangaben: | A. Chaturvedi, L. Herbst, S. Pusch, L. Klett, R. Goparaju, D. Stichel, S. Kaulfuss, O. Panknin, K. Zimmermann, L. Toschi, R. Neuhaus, A. Haegebarth, H. Rehwinkel, H. Hess-Stumpp, M. Bauser, T. Bochtler, E.A. Struys, A. Sharma, A. Bakkali, R. Geffers, M.M. Araujo-Cruz, F. Thol, R. Gabdoulline, A. Ganser, A.D. Ho, A. von Deimling, K. Rippe, M. Heuser and A. Krämer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1559164654 | ||
| 003 | DE-627 | ||
| 005 | 20220813180256.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170531s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/leu.2017.46 |2 doi | |
| 035 | |a (DE-627)1559164654 | ||
| 035 | |a (DE-576)48916465X | ||
| 035 | |a (DE-599)BSZ48916465X | ||
| 035 | |a (OCoLC)1340975877 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Chaturvedi, Anuhar |d 1978- |e VerfasserIn |0 (DE-588)133315959 |0 (DE-627)540523437 |0 (DE-576)299766632 |4 aut | |
| 245 | 1 | 0 | |a Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo |c A. Chaturvedi, L. Herbst, S. Pusch, L. Klett, R. Goparaju, D. Stichel, S. Kaulfuss, O. Panknin, K. Zimmermann, L. Toschi, R. Neuhaus, A. Haegebarth, H. Rehwinkel, H. Hess-Stumpp, M. Bauser, T. Bochtler, E.A. Struys, A. Sharma, A. Bakkali, R. Geffers, M.M. Araujo-Cruz, F. Thol, R. Gabdoulline, A. Ganser, A.D. Ho, A. von Deimling, K. Rippe, M. Heuser and A. Krämer |
| 264 | 1 | |c 24 February 2017 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.11.2017 | ||
| 520 | |a Neomorphic mutations in isocitrate dehydrogenase 1 (IDH1) are frequently found in several human cancer types including acute myeloid leukemia (AML) and lead to the production of high levels of the oncometabolite (R)-2-hydroxyglutarate (R-2HG). Here we report the characterization of BAY1436032, a novel pan-mutant IDH1 inhibitor, both in vitro and in vivo. BAY1436032 specifically inhibits R-2HG production and colony growth, and induces myeloid differentiation of AML cells carrying IDH1R132H, IDH1R132C, IDH1R132G, IDH1R132L and IDH1R132S mutations. In addition, the compound impacts on DNA methylation and attenuates histone hypermethylation. Oral administration of BAY1436032 led to leukemic blast clearance, myeloid differentiation, depletion of leukemic stem cells and prolonged survival in two independent patient-derived xenograft IDH1 mutant AML mouse models. Together, BAY1436032 is highly effective against all major types of IDH1 mutant AML. | ||
| 700 | 1 | |a Pusch, Stefan |d 1979- |e VerfasserIn |0 (DE-588)137014155 |0 (DE-627)58945224X |0 (DE-576)30150623X |4 aut | |
| 700 | 1 | |a Stichel, Damian |e VerfasserIn |0 (DE-588)1078124507 |0 (DE-627)838010059 |0 (DE-576)359423566 |4 aut | |
| 700 | 1 | |a Bochtler, Tilmann |d 1975- |e VerfasserIn |0 (DE-588)128398957 |0 (DE-627)372639925 |0 (DE-576)187323909 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Deimling, Andreas von |d 1959- |e VerfasserIn |0 (DE-588)103034115X |0 (DE-627)735093946 |0 (DE-576)378138065 |4 aut | |
| 700 | 1 | |a Rippe, Karsten |e VerfasserIn |0 (DE-588)102853261X |0 (DE-627)730885070 |0 (DE-576)168897989 |4 aut | |
| 700 | 1 | |a Krämer, Alwin |e VerfasserIn |0 (DE-588)1067780025 |0 (DE-627)819183431 |0 (DE-576)426900820 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 31(2017), 10, Seite 2020-2028 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo |
| 773 | 1 | 8 | |g volume:31 |g year:2017 |g number:10 |g pages:2020-2028 |g extent:9 |a Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/leu.2017.46 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/leu/journal/vaop/ncurrent/full/leu201746a.html |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170531 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1067780025 |a Krämer, Alwin |m 1067780025:Krämer, Alwin |d 910000 |d 910100 |e 910000PK1067780025 |e 910100PK1067780025 |k 0/910000/ |k 1/910000/910100/ |p 29 |y j | ||
| 998 | |g 102853261X |a Rippe, Karsten |m 102853261X:Rippe, Karsten |d 700000 |d 716000 |d 700000 |d 718000 |e 700000PR102853261X |e 716000PR102853261X |e 700000PR102853261X |e 718000PR102853261X |k 0/700000/ |k 1/700000/716000/ |k 0/700000/ |k 1/700000/718000/ |p 27 | ||
| 998 | |g 103034115X |a Deimling, Andreas von |m 103034115X:Deimling, Andreas von |d 910000 |d 912000 |e 910000PD103034115X |e 912000PD103034115X |k 0/910000/ |k 1/910000/912000/ |p 26 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 25 | ||
| 998 | |g 128398957 |a Bochtler, Tilmann |m 128398957:Bochtler, Tilmann |d 60000 |d 61400 |e 60000PB128398957 |e 61400PB128398957 |k 0/60000/ |k 1/60000/61400/ |p 16 | ||
| 998 | |g 1078124507 |a Stichel, Damian |m 1078124507:Stichel, Damian |d 700000 |d 716000 |e 700000PS1078124507 |e 716000PS1078124507 |k 0/700000/ |k 1/700000/716000/ |p 6 | ||
| 998 | |g 137014155 |a Pusch, Stefan |m 137014155:Pusch, Stefan |d 910000 |d 911100 |e 910000PP137014155 |e 911100PP137014155 |k 0/910000/ |k 1/910000/911100/ |p 3 | ||
| 999 | |a KXP-PPN1559164654 |e 2970512092 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["A. Chaturvedi, L. Herbst, S. Pusch, L. Klett, R. Goparaju, D. Stichel, S. Kaulfuss, O. Panknin, K. Zimmermann, L. Toschi, R. Neuhaus, A. Haegebarth, H. Rehwinkel, H. Hess-Stumpp, M. Bauser, T. Bochtler, E.A. Struys, A. Sharma, A. Bakkali, R. Geffers, M.M. Araujo-Cruz, F. Thol, R. Gabdoulline, A. Ganser, A.D. Ho, A. von Deimling, K. Rippe, M. Heuser and A. Krämer"]},"note":["Gesehen am 15.11.2017"],"physDesc":[{"extent":"9 S."}],"language":["eng"],"title":[{"title_sort":"Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo","title":"Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo"}],"relHost":[{"pubHistory":["Nachgewiesen 11.1997 -"],"disp":"Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivoLeukemia","part":{"extent":"9","issue":"10","year":"2017","text":"31(2017), 10, Seite 2020-2028","pages":"2020-2028","volume":"31"},"recId":"32046699X","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 15.03.04"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia","title_sort":"Leukemia"}],"language":["eng"],"id":{"zdb":["2008023-2"],"eki":["32046699X"],"issn":["1476-5551"]},"origin":[{"publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedDisp":"1997-","dateIssuedKey":"1997","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}]}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"family":"Chaturvedi","display":"Chaturvedi, Anuhar","role":"aut","given":"Anuhar"},{"role":"aut","display":"Pusch, Stefan","family":"Pusch","given":"Stefan"},{"family":"Stichel","display":"Stichel, Damian","role":"aut","given":"Damian"},{"display":"Bochtler, Tilmann","family":"Bochtler","role":"aut","given":"Tilmann"},{"given":"Anthony Dick","role":"aut","family":"Ho","display":"Ho, Anthony Dick"},{"display":"Deimling, Andreas von","family":"Deimling","role":"aut","given":"Andreas von"},{"given":"Karsten","family":"Rippe","display":"Rippe, Karsten","role":"aut"},{"given":"Alwin","display":"Krämer, Alwin","family":"Krämer","role":"aut"}],"id":{"doi":["10.1038/leu.2017.46"],"eki":["1559164654"]},"recId":"1559164654","origin":[{"dateIssuedDisp":"24 February 2017","dateIssuedKey":"2017"}]} | ||
| SRT | |a CHATURVEDIPANMUTANTI2420 | ||